This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Johnson, C. D. Articles by Slack, F. J. Search for Related Content PubMed PubMed Citation Articles by Johnson, C. D. Articles by Slack, F. J.

The let-7 MicroRNA Represses Cell Proliferation Pathways in Human Cells

¹ Asuragen, Inc.; ² Ambion, Inc., Austin, Texas, and ³ Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, Connecticut

Requests for reprints: Frank J. Slack, Department of Molecular, Cellular and Developmental Biology, P.O. Box 208103, Yale University, New Haven, CT 06520. Phone: 203-432-3492; Fax: 203-432-6161; E-mail: frank.slack{at}yale.edu or David Brown, Asuragen, Inc., 2150 Woodward St., Austin, TX 78744. E-mail: dbrown{at}asuragen.com.

MicroRNAs play important roles in animal development, cell differentiation, and metabolism and have been implicated in human cancer. The let-7 microRNA controls the timing of cell cycle exit and terminal differentiation in Caenorhabditis elegans and is poorly expressed or deleted in human lung tumors. Here, we show that let-7 is highly expressed in normal lung tissue, and that inhibiting let-7 function leads to increased cell division in A549 lung cancer cells. Overexpression of let-7 in cancer cell lines alters cell cycle progression and reduces cell division, providing evidence that let-7 functions as a tumor suppressor in lung cells. let-7 was previously shown to regulate the expression of the RAS lung cancer oncogenes, and our work now shows that multiple genes involved in cell cycle and cell division functions are also directly or indirectly repressed by let-7. This work reveals the let-7 microRNA to be a master regulator of cell proliferation pathways. [Cancer Res 2007;67(16):7713–22]

This article has been cited by other articles:

				B. Boyerinas, S.-M. Park, N. Shomron, M. M. Hedegaard, J. Vinther, J. S. Andersen, C. Feig, J. Xu, C. B. Burge, and M. E. Peter Identification of Let-7-Regulated Oncofetal Genes Cancer Res., April 15, 2008; 68(8): 2587 - 2591. [Abstract] [Full Text] [PDF]

				M. Cevec, C. Thibaudeau, and J. Plavec Solution structure of a let-7 miRNA:lin-41 mRNA complex from C. elegans Nucleic Acids Res., April 1, 2008; 36(7): 2330 - 2337. [Abstract] [Full Text] [PDF]

				S.-M. Park, A. B. Gaur, E. Lengyel, and M. E. Peter The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2 Genes & Dev., April 1, 2008; 22(7): 894 - 907. [Abstract] [Full Text] [PDF]

				M. S. Kumar, S. J. Erkeland, R. E. Pester, C. Y. Chen, M. S. Ebert, P. A. Sharp, and T. Jacks Suppression of non-small cell lung tumor development by the let-7 microRNA family PNAS, March 11, 2008; 105(10): 3903 - 3908. [Abstract] [Full Text] [PDF]

				J. B. Weidhaas, I. Babar, S. M. Nallur, P. Trang, S. Roush, M. Boehm, E. Gillespie, and F. J. Slack MicroRNAs as Potential Agents to Alter Resistance to Cytotoxic Anticancer Therapy Cancer Res., December 1, 2007; 67(23): 11111 - 11116. [Abstract] [Full Text] [PDF]